Efficacy and Safety of High-Dose Erythropoietin Combined with Hypothermia Therapy in Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review and Meta-Analysis
Authors:
- 27 March 2025
- journal article
- review article
- Published by Springer Nature in Molecular Biotechnology
- Vol. 68 (3) , 987-997
Abstract
This study was conducted to systematically evaluate the effectiveness and safety of high-dose erythropoietin (EPO) combined with hypothermia in treating neonatal hypoxic-ischemic encephalopathy (HIE) using meta-analysis (MA) and providing insights for the clinical application of this treatment approach. Clinical randomized controlled trials on EPO combined with hypothermia for neonatal HIE were identified through computer searches of databases, including Chinese National Knowledge Infrastructure (CNKI), Web of Sciences, Embase, and PubMed up to May 20, 2024. Screening, data extraction, and quality assessment were independently performed by two researchers, with MA conducted using RevMan5.3. 12 studies involving 1562 infants were included. MA results indicated greatly lower odds in the EPO group (EG) versus the Control group (CG) for mortality, acute brain injury, intellectual developmental index < 70, and motor developmental index < 70 [odds ratio (OR) = 0.65, 95%CI = 0.47–0.91, p = 0.01; OR = 0.51, 95%CI = 0.25–1.01, p = 0.05; OR = 0.47, 95%CI = 0.22–1.00, p = 0.05; OR = 0.44, 95%CI = 0.20–1.00, p = 0.05]. EG and CG demonstrated neglectable differences in terms of hospital stay duration, renal failure/injury rate, incidence of neurological developmental abnormalities, and antiepileptic drug usage (p > 0.05). High-dose EPO combined with hypothermia in the treatment of neonatal HIE effectively reduced mortality rates and improved intellectual and motor developmental outcomes.Keywords
This publication has 42 references indexed in Scilit:
- EPO prevents neuroinflammation and relieves depression via JAK/STAT signalingLife Sciences, 2023
- Identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancerCancer Genetics, 2023
- Safety of High Dose Erythropoietin Used with Therapeutic Hypothermia as Treatment for Newborn Hypoxic-Ischemic Encephalopathy: Secondary Analysis of the HEAL Randomized Controlled TrialThe Journal of Pediatrics, 2023
- Mild controlled hypothermia for necrotizing enterocolitis treatment to preterm neonates: low technology technique description and safety analysisEuropean Journal of Pediatrics, 2022
- New possibilities for neuroprotection in neonatal hypoxic-ischemic encephalopathyEuropean Journal of Pediatrics, 2021
- The Term NewbornClinics in Perinatology, 2021
- Pathophysiology of hypoxic–ischemic encephalopathy: a review of the past and a view on the futureActa Neurologica Belgica, 2020
- Effects of water extract from epimedium on neuropeptide signaling in an ovariectomized osteoporosis rat modelJournal of Ethnopharmacology, 2018
- Erythropoietin and Brain Magnetic Resonance Imaging Findings in Hypoxic-Ischemic Encephalopathy: Volume of Acute Brain Injury and 1-Year Neurodevelopmental OutcomeThe Journal of Pediatrics, 2017
- Safety of Early High-Dose Recombinant Erythropoietin for Neuroprotection in Very Preterm InfantsThe Journal of Pediatrics, 2015